Stay updated on Flamboyant 125/12 in Moderate Asthma: Clinical Trial
Sign up to get notified when there's something new on the Flamboyant 125/12 in Moderate Asthma: Clinical Trial page.

Latest updates to the Flamboyant 125/12 in Moderate Asthma: Clinical Trial page
- Check7 days agoChange DetectedThe study page now displays details for the Flamboyant 125/12 asthma trial, including its design, participant criteria, Brazilian locations, and efficacy and safety measures, rather than an access-denied error.SummaryDifference48%

- Check14 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA notice was added at the top of the page announcing NIH website updates and the use of “Super Intelligence” in place of “Artificial Intelligence.” The clinical trial record remains inaccessible behind a 403 error.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision was updated from v3.7.1 to v3.7.2; the 403 error page otherwise remains unchanged.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with a generic error page and minimal site chrome. This indicates restricted access to the study record rather than an update to the study details.SummaryDifference18%

Stay in the know with updates to Flamboyant 125/12 in Moderate Asthma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flamboyant 125/12 in Moderate Asthma: Clinical Trial page.